We confirmed CSC formation by analyzing the expression levels of CSC markers, NANOG, POU5F1 and SOX2, in the UA-treated NSCLC cells, and found these genes to be significantly inhibited (Figure 4B). The gene discussed is SOX2; the disease is non-small cell lung carcinoma.